NovelStem International Corp.
OTC: NSTM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jan H. Loeb
- Headquarters
- Boca Raton, United States
- IPO year
- 1993
- Market cap
- $493.3K
- Website
- https://www.novelstem.com
Loading NSTM…
Loading profile data…Frequently asked questions about NSTM
What does NovelStem International Corp. (NSTM) do?
NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance. The company, which commenced operations in 1993, was previously recognized as Hollywood Media Corp. before adopting its current name in September of 2018...
Where does NSTM trade?
NovelStem International Corp. (NSTM) trades on the Other OTC.
What sector is NSTM in?
NovelStem International Corp. (NSTM) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of NovelStem International Corp.?
Jan H. Loeb is the chief executive officer of NovelStem International Corp. (NSTM).
Where is NovelStem International Corp. headquartered?
NovelStem International Corp. is headquartered in United States.
Does NSTM pay a dividend?
NovelStem International Corp. (NSTM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NSTM go public?
NovelStem International Corp. (NSTM) completed its initial public offering in 1993.